HLA class II-mediated death is induced via Fas/Fas ligand interactions in human splenic B lymphocytes

Détails

ID Serval
serval:BIB_25C0A991384E
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
HLA class II-mediated death is induced via Fas/Fas ligand interactions in human splenic B lymphocytes
Périodique
Blood
Auteur⸱e⸱s
Truman  J. P., Choqueux  C., Tschopp  J., Vedrenne  J., Le Deist  F., Charron  D., Mooney  N.
ISSN
0006-4971 (Print)
Statut éditorial
Publié
Date de publication
03/1997
Volume
89
Numéro
6
Pages
1996-2007
Notes
Journal Article
Research Support, Non-U.S. Gov't --- Old month value: Mar 15
Résumé
HLA class II molecules, expressed on the surface of antigen-presenting cells, are responsible for the presentation of antigen-derived peptides to CD4+ helper T lymphocytes. Signaling via these molecules initiates the generation of second messengers leading to programed cell death (PCD) of activated B lymphocytes. The present study examined the mechanism of HLA class II-mediated apoptosis and describes the essential role of the molecule Fas and its ligand (FasL). FasL was expressed in B lymphocytes after stimulation via HLA class II or with phorbol esters. Expression of FasL protein was significantly increased in 50% of B lymphocytes after stimulation via HLA class II, and the level of FasL mRNA was also increased either by activation with phorbol esters and ionomycin or by signaling via HLA class II. Although HLA class II signaling did not change the expression of the Fas molecule, it did lead to increased sensitivity to Fas-mediated apoptosis. The crucial role of Fas/FasL interactions was confirmed by the absence of cell death via HLA class II in B cells lacking Fas expression, and by the significant inhibition of HLA class II-mediated apoptosis in the presence of either an antagonistic anti-Fas or anti-FasL antibody. These data demonstrate FasL expression on activated human B lymphocytes and support the idea that antigen presentation could contribute to the regulation of lymphocyte populations via Fas and FasL interactions.
Mots-clé
Antibodies, Blocking/pharmacology Antibodies, Monoclonal/pharmacology Antigens, CD95/immunology/*metabolism Apoptosis/*immunology B-Lymphocytes/*immunology/*metabolism Fas Ligand Protein Histocompatibility Antigens Class II/*physiology Humans Ligands Lymphocyte Activation Membrane Glycoproteins/biosynthesis/genetics/immunology/*metabolism RNA, Messenger/biosynthesis Signal Transduction/immunology Spleen/cytology/immunology
Pubmed
Web of science
Création de la notice
24/01/2008 16:18
Dernière modification de la notice
20/08/2019 14:04
Données d'usage